NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF (1621.TSE) — Technical state
As of 2026-08-14 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.
Trades +2.5% vs the 50-day and +0.1% vs the 200-day average, 11.9% below the 52-week high and +18.7% off the 52-week low; a death cross printed 29 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+1.4%
- vs 50-day+2.5%
- vs 200-day+0.1%
- 52-week band11.9% off the high · +18.7% off the low
- Streak3 consecutive down sessions
- CrossoverDeath cross 29 sessions ago
- 50-day crossprice crossed up through the 50-day 5 sessions ago
- Stochastic%K 70.7 · %D 83.6 · bear cross
Continue: the 1621.TSE chart & overview · the signal board
FAQ · from the current data · as of 2026-08-14
Quick answers
What is the current Closelook signal on 1621.TSE?
Recovery attempt under the 200-day — Trades +2.5% vs the 50-day and +0.1% vs the 200-day average, 11.9% below the 52-week high and +18.7% off the 52-week low; a death cross printed 29 sessions ago. Computed from daily closes. As of 2026-08-14; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is 1621.TSE above its 50-day and 200-day moving averages?
As of 2026-08-14, NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF trades +2.5% above its 50-day and +0.1% above its 200-day average, with the 20-day +1.4% away.
How far is 1621.TSE from its 52-week high?
11.9% below the 52-week high and 18.7% above the 52-week low, as of 2026-08-14.